CRLF2 and acute lymphoblastic leukemia: In addition to JAK‐STAT, we have identified several deregulated pathways in CRLF2‐r ALL, for example, focal adhesion signaling, one which has not previously been implicated in this subtype of ALL and was enriched in patients with both IGH‐ and P2RY8‐CRLF2 ALL.